Hippocampal O
involvement O
in O
nonpathological O
déjà O
vu O
: O
Subfield O
vulnerability O
rather O
than O
temporal O
lobe O
epilepsy O
equivalent O
Abstract O
Introduction O
Morphological O
correlates O
of O
nonpathological O
déjà O
vu O
( O
DV O
) O
have O
been O
identified O
recently O
within O
the O
human O
brain O
. O

Significantly O
reduced O
gray O
matter O
volume O
( O
GMV O
) O
within O
a O
set O
of O
cortical O
and O
subcortical O
regions O
reported O
in O
subjects O
experiencing O
DV O
seems O
to O
mirror O
the O
distribution O
of O
GMV O
reduction O
in O
mesial O
temporal O
lobe O
epilepsy O
( O
MTLE O
) O
patients O
but O
vary O
in O
terms O
of O
the O
hippocampus O
. O

Another O
condition O
associated O
with O
hippocampal O
GMV O
reduction O
and O
DV O
alike O
disturbance O
in O
memory O
processing O
is O
schizophrenia O
( O
SCH O
) O
. O

Here O
, O
we O
tested O
the O
hypothesis O
that O
hippocampal O
involvement O
in O
nonpathological O
DV O
resembles O
more O
closely O
the O
pattern O
of O
GMV O
decrease O
observed O
in O
MTLE O
compared O
with O
that O
occurring O
in O
SCH O
. O

Methods O
Using O
automated O
segmentation O
of O
the O
MRI O
data O
we O
compared O
the O
medians O
of O
GMV O
within O
12 O
specific O
hippocampal O
subfields O
in O
healthy O
individuals O
that O
do O
( O
DV+ O
; O
N O
= O
87 O
) O
and O
do O
not O
report O
déjà O
vu O
experience O
( O
DV− O
; O
N O
= O
26 O
) O
, O
and O
patients O
with O
MTLE O
( O
N O
= O
47 O
) O
and O
SCH O
( O
N O
= O
29 O
) O
. O

By O
Pearson O
correlation O
, O
we O
then O
evaluated O
the O
similarity O
of O
MTLE O
and O
SCH O
groups O
to O
DV+ O
group O
with O
respect O
to O
spatial O
distribution O
of O
GMV O
deviation O
from O
DV− O
group O
. O

Results O
Significant O
GMV O
decrease O
was O
found O
in O
MTLE O
group O
in O
most O
of O
the O
subfields O
. O

There O
were O
just O
trends O
in O
the O
hippocampal O
GMV O
decrease O
found O
in O
DV+ O
or O
SCH O
groups O
. O

Concerning O
the O
spatial O
distribution O
of O
GMV O
decrease O
, O
we O
revealed O
statistically O
significant O
correlation O
for O
the O
left O
hippocampus O
for O
SCH O
vs O
DV+ O
. O

Otherwise O
there O
was O
no O
statistically O
significant O
correlation O
. O

Conclusions O
Our O
findings O
reveal O
structural O
features O
of O
hippocampal O
involvement O
in O
nonpathological O
DV O
, O
MTLE O
, O
and O
SCH O
. O

Despite O
our O
expectations O
, O
the O
pattern O
of O
GMV O
reduction O
in O
the O
DV+ O
relative O
to O
the O
DV− O
group O
does O
not O
resemble O
the O
pattern O
observed O
in O
MTLE O
any O
more O
than O
that O
observed O
in O
SCH O
. O

The O
highly O
similar O
patterns O
of O
the O
three O
clinical O
groups O
rather O
suggest O
an O
increased O
vulnerability O
of O
certain O
hippocampal O
subfields O
; O
namely O
, O
Cornu O
Ammonis O
( O
CA O
) O
4 O
, O
CA3 O
, O
dentate O
gyrus O
granular O
cell O
layer O
( O
GC‐DG O
) O
, O
hippocampal–amygdaloid O
transition O
area O
( O
HATA O
) O
and O
subiculum O
. O

METHODS O
Subjects O
Our O
sample O
comprised O
a O
total O
of O
189 O
subjects O
participated O
in O
the O
study O
. O

The O
MTLE O
group O
consisted O
of O
a O
left‐sided O
( O
L‐MTLE O
; O
N O
= O
27 O
; O
8M O
, O
19F O
; O
median O
age O
= O
40.2 O
years O
; O
range O
= O
17.7 O
– O
54.6 O
years O
) O
and O
right‐sided O
subgroup O
( O
R‐MTLE O
; O
N O
= O
20 O
; O
6M O
, O
14F O
; O
median O
age O
= O
38.2 O
years O
; O
range O
= O
24.8 O
– O
61.1 O
years O
) O
. O

For O
the O
L‐MTLE O
subgroup O
, O
the O
median O
age O
at O
the O
time O
of O
disease O
onset O
was O
3 O
years O
( O
range O
1 O
– O
35 O
years O
) O
, O
the O
median O
disease O
duration O
was O
32.5 O
years O
( O
range O
6 O
– O
54 O
years O
) O
, O
and O
the O
median O
seizure O
frequency O
was O
4 O
seizures O
per O
month O
( O
range O
2 O
– O
135 O
seizures O
) O
. O

For O
the O
R‐MTLE O
subgroup O
, O
the O
median O
age O
at O
the O
time O
of O
the O
disease O
onset O
was O
5.5 O
years O
( O
range O
8 O
months O
– O
40 O
years O
) O
, O
the O
median O
disease O
duration O
was O
29.5 O
years O
( O
range O
8 O
– O
55 O
years O
) O
, O
and O
the O
median O
seizure O
frequency O
was O
4.75 O
seizures O
per O
month O
( O
1 O
– O
13 O
) O
. O

At O
the O
time O
of O
testing O
, O
the O
subgroups O
did O
not O
differ O
significantly O
in O
age O
( O
p O
= O
.97 O
, O
T–test O
) O
, O
gender O
( O
p O
= O
.48 O
; O
T–test O
) O
, O
disease O
duration O
( O
p O
= O
.60 O
, O
T–test O
) O
or O
seizure O
frequency O
( O
p O
= O
.40 O
, O
T–test O
) O
. O

There O
was O
no O
significant O
variance O
between O
the O
subgroups O
in O
their O
positive O
history O
of O
febrile O
convulsions O
( O
seven O
in O
L‐MTLE O
and O
six O
in O
R‐MTLE O
; O
p O
= O
.74 O
, O
T–test O
) O
. O

Majority O
of O
the O
subjects O
had O
a O
history O
of O
complex O
partial O
seizures O
. O

Ten O
patients O
in O
the O
L‐MTLE O
subgroup O
and O
eight O
patients O
in O
the O
R‐MTLE O
subgroup O
also O
presented O
secondary O
generalized O
seizures O
. O

One O
patient O
with O
L‐MTLE O
and O
one O
with O
R‐MTLE O
had O
simple O
partial O
seizures O
. O

DV O
in O
the O
context O
of O
aura O
was O
reported O
solely O
by O
one O
patient O
. O

The O
only O
statistically O
significant O
divergence O
between O
the O
subgroups O
was O
in O
the O
number O
of O
prescribed O
antiepileptic O
drugs O
( O
number O
of O
types O
) O
: O
a O
mean O
of O
2.3 O
medications O
for O
the O
L‐MTLE O
subgroup O
, O
and O
a O
mean O
of O
1.8 O
medications O
for O
R‐MTLE O
subgroup O
( O
p O
= O
.03 O
, O
T‐test O
) O
. O

The O
diagnosis O
of O
unilateral O
MTLE O
was O
based O
on O
a O
consonance O
of O
history O
data O
, O
ictal O
and O
interictal O
EEG O
findings O
( O
long‐term O
semi‐invasive O
video‐EEG O
monitoring O
with O
sphenoidal O
electrodes O
) O
, O
ictal O
semiology O
, O
neuropsychology O
, O
neuroimaging O
findings O
, O
and O
fulfillment O
of O
the O
diagnostic O
criteria O
for O
MTLE O
according O
to O
the O
International O
League O
Against O
Epilepsy O
( O
ILAE O
) O
criteria O
( O
Commission O
on O
Classification O
and O
Terminology O
of O
ILAE O
, O
1989 O
) O
. O

As O
another O
inclusion O
criteria O
was O
set O
also O
hippocampal O
sclerosis O
, O
which O
is O
a O
substrate O
characterizing O
classical O
TLE O
( O
Hogan O
, O
2001 O
) O
. O

Unilateral O
hippocampal O
sclerosis O
MRI O
evidence O
concordant O
with O
the O
EEG O
lateralization O
of O
the O
epileptogenic O
zone O
was O
found O
in O
all O
subjects O
. O

None O
of O
the O
subjects O
revealed O
any O
other O
structural O
brain O
lesions O
on O
MRI O
scans O
, O
and O
none O
had O
undergone O
previous O
intracranial O
surgery O
. O

All O
subjects O
had O
been O
seizure O
free O
for O
24 O
hr O
prior O
to O
the O
MRI O
investigation O
. O

The O
SCH O
group O
comprised O
of O
29 O
subjects O
( O
23M O
, O
6F O
; O
median O
age O
= O
33 O
years O
; O
range O
= O
19.3 O
– O
45.1 O
years O
) O
with O
a O
median O
disease O
duration O
of O
4.5 O
years O
( O
range O
= O
1 O
‐ O
288 O
months O
) O
. O

The O
symptom O
severity O
in O
these O
patients O
was O
assessed O
with O
Positive O
and O
Negative O
Syndrome O
Scale O
( O
PANSS O
; O
Kay O
, O
Fiszbein O
, O
& O
Opler O
, O
1987 O
) O
. O

Patients O
scored O
a O
median O
of O
14 O
points O
( O
range O
= O
7 O
– O
20 O
points O
) O
on O
the O
positive O
scale O
, O
a O
median O
score O
of O
21 O
points O
( O
range O
= O
10 O
– O
29 O
points O
) O
on O
the O
negative O
scale O
, O
and O
a O
median O
of O
38 O
points O
( O
range O
= O
21 O
– O
53 O
points O
) O
on O
the O
general O
psychopathology O
scale O
. O

The O
median O
of O
experienced O
episodes O
was O
2 O
( O
range O
= O
1 O
‐ O
8 O
episodes O
) O
during O
the O
course O
of O
the O
disease O
, O
and O
all O
subjects O
were O
on O
stable O
antipsychotic O
medication O
with O
median O
of O
1 O
( O
range O
= O
1‐2 O
drugs O
, O
all O
atypical O
antipsychotics O
) O
. O

None O
of O
the O
subjects O
reported O
history O
of O
epilepsy O
or O
signs O
of O
hippocampal O
sclerosis O
on O
MRI O
. O

The O
DV+ O
group O
comprised O
of O
87 O
healthy O
volunteers O
( O
45M O
, O
42F O
; O
median O
age O
= O
24.1 O
years O
; O
range O
= O
19.1 O
– O
46.2 O
years O
) O
with O
no O
personal O
or O
family O
history O
of O
epilepsy O
or O
schizophrenia O
. O

All O
subjects O
completed O
the O
Inventory O
for O
Déjà O
vu O
Experiences O
Assessment O
( O
IDEA O
) O
—a O
questionnaire O
used O
widely O
in O
previous O
DV O
research O
( O
Sno O
, O
Schalken O
, O
de O
Jonghe O
, O
& O
Koeter O
, O
1994 O
) O
—and O
answered O
“ O
yes O
” O
to O
the O
question O
A1 O
: O
” O
Have O
you O
ever O
had O
the O
feeling O
of O
having O
experienced O
a O
sensation O
or O
situation O
before O
in O
exactly O
the O
same O
way O
when O
in O
fact O
you O
are O
experiencing O
it O
for O
the O
first O
time O
? O
” O
. O

The O
DV− O
group O
included O
26 O
healthy O
volunteers O
( O
14M O
, O
12F O
; O
median O
age O
= O
24.2 O
years O
; O
range O
= O
20.3 O
– O
49.5 O
years O
) O
with O
no O
personal O
or O
family O
history O
of O
epilepsy O
or O
schizophrenia O
. O

These O
individuals O
answered O
“ O
never O
” O
to O
question O
A1 O
of O
the O
IDEA O
questionnaire O
. O

Group O
factor O
testing O
reached O
statistical O
significance O
in O
the O
case O
of O
age O
( O
Kruskal‐Wallis O
test O
H O
[ O
4,189 O
] O
= O
59.6 O
, O
p O
< O
.001 O
) O
and O
gender O
( O
Pearson O
Chi‐square O
test O
, O
chi‐square O
= O
17.9 O
, O
p O
= O
.001 O
) O
. O

Written O
informed O
consent O
was O
obtained O
from O
each O
participant O
after O
all O
the O
procedures O
were O
explained O
in O
full O
. O

The O
study O
received O
the O
approval O
of O
the O
local O
ethics O
committee O
. O

MRI O
data O
acquisition O
We O
acquired O
a O
T1 O
MPRAGE O
high O
resolution O
MRI O
for O
each O
subject O
with O
a O
Siemens O
Symphony O
1.5T O
MR O
scanner O
( O
160 O
sagittal O
slices O
; O
matrix O
size O
256 O
× O
256 O
, O
resampled O
to O
512 O
× O
512 O
; O
TR O
= O
1,700 O
ms O
; O
TE O
= O
3.96 O
ms O
; O
FOV O
= O
246 O
mm O
; O
FA O
= O
15° O
; O
slice O
thickness O
= O
1.17 O
mm O
; O
native O
in O
plane O
resolution O
= O
0.96 O
mm O
) O
. O

Eight O
images O
were O
discarded O
due O
to O
severe O
motion O
artifacts O
identified O
by O
visual O
inspection O
. O

The O
resulting O
images O
comprised O
the O
data O
described O
above O
and O
analyzed O
as O
follows O
. O

MRI O
data O
preprocessing O
We O
used O
the O
Freesurfer O
6.0 O
toolbox O
for O
data O
preprocessing O
with O
additional O
tool O
for O
hippocampal O
subfields O
segmentation O
( O
recon‐all O
–all O
–hippocampal‐subfields‐T1 O
command O
) O
( O
Iglesias O
et O
al. O
, O
2015 O
) O
. O

The O
output O
of O
the O
preprocessing O
contained O
an O
information O
of O
the O
hippocampal O
subfields O
volumes O
, O
namely O
parasubiculum O
, O
presubiculum O
, O
subiculum O
, O
CA1 O
, O
CA3 O
, O
CA4 O
, O
GC‐DG O
, O
HATA O
, O
fimbria O
, O
molecular O
layer O
HP O
, O
fissure O
and O
tail O
as O
well O
as O
an O
estimate O
of O
the O
total O
intracranial O
volume O
( O
TIV O
) O
. O

The O
subfield O
volumes O
were O
corrected O
for O
age O
and O
gender O
effects O
using O
linear O
regression O
and O
for O
variability O
in O
head O
volume O
using O
normalization O
by O
TIV O
. O

We O
refer O
to O
these O
values O
as O
corrected O
subfield O
volumes O
( O
CSV O
) O
. O

Statistics O
The O
purpose O
of O
the O
study O
was O
to O
map O
GMV O
within O
distinctive O
hippocampal O
subfields O
, O
and O
to O
perform O
comparisons O
in O
these O
measures O
of O
GMV O
among O
the O
DV+ O
, O
DV− O
, O
SCH O
, O
and O
MTLE O
groups O
. O

We O
carried O
out O
two O
statistical O
tests O
with O
the O
STATISTICA O
12 O
( O
StatSoft O
, O
Inc. O
, O
USA O
) O
. O

Subfield O
specific O
GMV O
decrease O
To O
reveal O
subfield O
specific O
GMV O
change O
in O
DV+ O
, O
SCH O
, O
and O
MTLE O
group O
relative O
to O
the O
DV− O
group O
, O
we O
performed O
Mann‐Whitney O
tests O
on O
CSV O
for O
each O
subfield O
and O
group O
( O
DV+ O
, O
SCH O
and O
MTLE O
vs. O
DV− O
) O
. O

The O
significance O
level O
was O
set O
to O
p O
< O
.05 O
. O

Spatial O
distribution O
of O
GMV O
decrease O
We O
computed O
median O
of O
the O
CSV O
volumes O
( O
mCSV O
) O
across O
subjects O
for O
each O
group O
and O
subfield O
. O

To O
identify O
which O
patient O
group O
resembles O
more O
the O
DV+ O
group O
considering O
the O
spatial O
pattern O
of O
GMV O
deviations O
from O
DV− O
we O
further O
computed O
the O
deviation O
of O
mCSV O
between O
DV+/MTLE/SCH O
and O
DV− O
( O
dmSCV O
) O
. O

The O
dmCSV O
patterns O
were O
assessed O
using O
Pearson O
correlation O
coefficient O
, O
that O
is O
, O
we O
computed O
correlation O
coefficient O
based O
on O
dmSCV O
for O
DV+ O
vs O
MTLE O
in O
affected O
hippocampus O
and O
DV+ O
vs O
SCH O
in O
both‐sided O
hippocampi O
. O

The O
significance O
level O
of O
correlation O
coefficients O
was O
set O
to O
p O
< O
.05 O
. O

